Immunoassay Interference Blocker Market Share Report, 2032

Immunoassay Interference Blocker Market – By Product (Surface Interference, Antibody & Detection Interference Blocker), Application (Sandwich Immunoassay, Competitive ELISA), Technology (ELISA, CLIA, FIA), End-use – Global Forecast (2024 – 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 360&ordm; synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rise in prevalence of chronic disease

3.2.1.2&nbsp;&nbsp;&nbsp; Technological advancement in immunoassay interference blocker

3.2.1.3&nbsp;&nbsp;&nbsp; Increase in demand for high accurate diagnostic devices

3.2.1.4&nbsp;&nbsp;&nbsp; Rising demand for biochemical testing

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High manufacturing cost of blocker

3.2.2.2&nbsp;&nbsp;&nbsp; Lack of awareness about the importance of interference blockers

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.6&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategic dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Antibody interference blocker

5.2.1&nbsp;&nbsp;&nbsp; Human serum derived

5.2.2&nbsp;&nbsp;&nbsp; Animal serum derived

5.2.3&nbsp;&nbsp;&nbsp; Human immunoglobulin blocker

5.2.4&nbsp;&nbsp;&nbsp; Animal polyclonal antibody

5.2.5&nbsp;&nbsp;&nbsp; Heterophilic blocking agent

5.3&nbsp;&nbsp;&nbsp; Detection interference blocker

5.3.1&nbsp;&nbsp;&nbsp; Enzyme blocker

5.3.2&nbsp;&nbsp;&nbsp; Beta-galactosidase blocker

5.3.3&nbsp;&nbsp;&nbsp; Alkaline phosphate blocker

5.4&nbsp;&nbsp;&nbsp; Surface interference

5.4.1&nbsp;&nbsp;&nbsp; Poly BSA blocker

5.4.2&nbsp;&nbsp;&nbsp; Bovine serum albumin blocker

5.4.3&nbsp;&nbsp;&nbsp; BSA fraction V blocker

5.4.4&nbsp;&nbsp;&nbsp; Blocking buffer

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Sandwich immunoassay

6.3&nbsp;&nbsp;&nbsp; Competitive ELISA

6.4&nbsp;&nbsp;&nbsp; Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Technology, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; ELISA

7.3&nbsp;&nbsp;&nbsp; Chemiluminescence immunoassays

7.4&nbsp;&nbsp;&nbsp; Fluorescence immunoassays

7.5&nbsp;&nbsp;&nbsp; Latex agglutination

7.6&nbsp;&nbsp;&nbsp; Other technologies

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-use, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Biotechnology companies

8.3&nbsp;&nbsp;&nbsp; Contract research organizations

8.4&nbsp;&nbsp;&nbsp; Academic &amp; research institutes

8.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Netherlands

9.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; Japan

9.4.2&nbsp;&nbsp;&nbsp; China

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; UAE

9.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp;Meridian Bioscience

10.2&nbsp;&nbsp;&nbsp;F. Hoffmann La Roche Ltd.

10.3&nbsp;&nbsp;&nbsp;Candor Bioscience GmbH

10.4&nbsp;&nbsp;&nbsp;Nordic Biosite

10.5&nbsp;&nbsp;&nbsp;Bio-Rad Laboratories Inc.

10.6&nbsp;&nbsp;&nbsp;Aviva Biosystem Biology Corporation

10.7&nbsp;&nbsp;&nbsp;Scantibodies Laboratory Inc.

10.8&nbsp;&nbsp;&nbsp;Rockland Immunochemicals Inc.

10.9&nbsp;&nbsp;&nbsp;Abcam PLC

10.10&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc.

10.11&nbsp;&nbsp;&nbsp; Surmodic IVD Inc.

10.12&nbsp;&nbsp;&nbsp; Electron Microscopy Science

10.13&nbsp;&nbsp;&nbsp; Merck KGaA

10.14&nbsp;&nbsp;&nbsp; Jackson ImmunoResearch Inc.

&nbsp;&nbsp;&nbsp;

Immunoassay Interference Blocker Market

Inquiry Before Buying